Clinical trial
Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's…
NCT00052416 · Beth Israel Deaconess Medical Center, Other · Completed
Key facts
| NCT number | NCT00052416 |
|---|---|
| Title | Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia |
| Official title | Thalidomide in Indolent Non-Hodgkin's Lymphoma: A Feasibility Study |
| Lead sponsor | Beth Israel Deaconess Medical Center, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Leukemia, Lymphoma |
| Intervention type | Drug |
| Interventions | thalidomide |
| Start date | Oct 1, 2002 |
| Completion | Jan 1, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: